REQUEST A DEMO
Total
USD $0.00
Search more companies

Exim Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Retail Trade | Warehousing and Storage | Rental and Leasing Services
Full name: Exim Pharma Sp. z o.o. Profile Updated: November 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

EXIM PHARMA Sp. z o.o is a manufacturer in the pharmaceutical industry, specializing in dietary supplements, medical products, and products for animals. They provide services in contract manufacturing, with a production facility capable of producing various forms of preparations, particularly those using active carbon. They also offer assistance in preparing documentation for regulatory authorities.

Headquarters
Ul. Ogrodowa 37/50
Warsaw; Mazowieckie; Postal Code: 00-873

Contact Details: Purchase the Exim Pharma Sp. z o.o. report to view the information.

Website: http://www.eximpharma.eu

Basic Information
Total Employees:
Purchase the Exim Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Exim Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Exim Pharma Sp. z o.o. report to view the information.
Incorporation Date:
November 27, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Exim Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
45.08%
Total operating revenue
44.26%
Operating profit (EBIT)
130.04%
EBITDA
132.39%
Net Profit (Loss) for the Period
145.39%
Total assets
51.8%
Total equity
240.87%
Operating Profit Margin (ROS)
8.53%
Net Profit Margin
8.74%
Return on Equity (ROE)
-22.02%
Debt to Equity Ratio
2.57%
Quick Ratio
1.31%
Cash Ratio
1.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?